Here, we describe a gene editing application for deletion of the CTG‐repeat expansion in the human DMPK gene both in cells derived from a DM1 patient and in DMSXL mice, using novel tools selected for high editing efficiency and specificity. This evidence concerns the gene DMPK and myotonic dystrophy type 1.